Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease — results from a randomized trial programme

Background : Helicobacter pylori infection has been proposed as a protective factor against the development of gastro‐oesophageal reflux disease.

[1]  P. Malfertheiner,et al.  Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report , 2002, Alimentary pharmacology & therapeutics.

[2]  G. Lindberg,et al.  Curing Helicobacter pylori Infection in Patients with Duodenal Ulcer Does Not Provoke Gastroesophageal Reflux Disease , 2000, Helicobacter.

[3]  F. Mégraud,et al.  The HOMER Study: The Effect of Increasing the Dose of Metronidazole When Given with Omeprazole and Amoxicillin to Cure Helicobacter pylori Infection , 2000, Helicobacter.

[4]  Kamada,et al.  High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis , 2000, Alimentary pharmacology & therapeutics.

[5]  E. El-Omar,et al.  Symptomatic benefit 1–3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease , 2000, American Journal of Gastroenterology.

[6]  Burman,et al.  Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection , 1999, Alimentary pharmacology & therapeutics.

[7]  T. Shimosegawa,et al.  Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis , 1999, American Journal of Gastroenterology.

[8]  A. Sonnenberg,et al.  Corpus gastritis is protective against reflux oesophagitis , 1999, Gut.

[9]  R. Spiller,et al.  The GU‐MACH study: the effect of 1‐week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer , 1999, Alimentary pharmacology & therapeutics.

[10]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[11]  O’morain,et al.  The DU‐MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy , 1999, Alimentary pharmacology & therapeutics.

[12]  O’connor.  Review article: Helicobacter pylori and gastro‐oesophageal reflux disease—clinical implications and management , 1999, Alimentary pharmacology & therapeutics.

[13]  R. Spiller,et al.  The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. , 1999, Gastroenterology.

[14]  Haruma,et al.  Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus—evaluation of 24‐h pH monitoring , 1999, Alimentary pharmacology & therapeutics.

[15]  M. Blaser,et al.  Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in the modern era , 1998, Gut.

[16]  N. Talley,et al.  No increase of reflux symptoms or esophagitis in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controled trial , 1998 .

[17]  A B West,et al.  An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. , 1998, Cancer research.

[18]  P. Malfertheiner,et al.  Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease. , 1998, Scandinavian journal of gastroenterology.

[19]  P. Malfertheiner,et al.  Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? , 1997, Gut.

[20]  E. El-Omar,et al.  Helicobacter pylori infection and chronic gastric acid hyposecretion. , 1997, Gastroenterology.

[21]  A. Blum,et al.  Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. , 1997, Gastroenterology.

[22]  K. Mccoll.  Helicobacter pylori and acid secretion: where are we now? , 1997, European journal of gastroenterology & hepatology.

[23]  E. Boyd.  The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia. , 1996, The American journal of gastroenterology.

[24]  T. Havelund,et al.  Interobserver variation in the endoscopic diagnosis of reflux esophagitis. , 1993, Scandinavian journal of gastroenterology.

[25]  A. Price.  The Sydney System: Histological division , 1991, Journal of gastroenterology and hepatology.

[26]  P. Kettunen,et al.  Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. , 1989, Gut.

[27]  Earlam Rj.  The gastro-oesophageal junction in duodenal ulcer. , 1971 .

[28]  R. Earlam.  Production of Epigastric Pain in Duodenal Ulcer by Lower Oesophageal Acid Perfusion , 1970, British medical journal.

[29]  S. Vollset,et al.  Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. , 1999, Scandinavian journal of gastroenterology.

[30]  R. Earlam.  The gastro-oesophageal junction in duodenal ulcer. , 1971, The British journal of surgery.